Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
Sizeable team with a full life sciences offering which includes coverage of anti-corruption, compliance, clinical trials, IP, regulatory and competition law issues. Particularly respected for its skilled handling of patent litigation, including infringement, amendment, revocation and enforcement for major pharmaceutical companies. Also noted for its experience handling high-value, cross-border transactional matters and commercialisation matters. Acts for a broad range of biotech, healthcare, pharmaceutical and vaccine companies. Boasts impressive geographical coverage, with offices in Australia, New Zealand, China, Japan, South Korea, Singapore and Thailand.
Clients point to the firm's global network as an important strength, one noting: "The firm has a well-established global presence, with international teams and partners working seamlessly to ensure a high level of client care and a consistent level of service. The global presence ensures that accurate local advice can be provided by numerous teams when dealing with international transactions and proposals."
Another client comments: "They provide excellent client engagement and responsiveness, and seek to understand our queries and offer practical advice."
Acted for Pfizer in one of the largest and most complex life sciences litigations / life sciences patent litigations in Australia ever, involving eight parties adverse to our clients.
Represented General Electric on the global internal restructuring of its GE Life Sciences (GE Biopharma) businesses and their subsequent disposal to Danaher Corporation.
Acted for Medtronic on a mission-critical ventilator supply-chain project.
Nicholas Tyacke and Sammy Fang are main contacts for the life sciences practice, based in Sydney and Hong Kong respectively.
This content is provided by DLA Piper LLP.
You can learn more about our practice at dlapiper.com.